The Endocrinology Network® Cardiology clinical resource center is a hub of news related to cardiovascular health that is relevant to clinicians interested in endocrinology. This page will host relevant content about cardiology and cardiovascular disease including guideline updates, new studies and breakthroughs, and clinical perspectives for practicing clinicians.

Diabetic Ketoacidosis Raises Risk of In-Hospital Mortality, Hospital Readmission in Heart Failure

May 17, 2022

Diabetic ketoacidosis increased the likelihood of in-hospital mortality by 61%, the likelihood of major adverse cardiovascular events by 56%, and a likelihood of 30-day readmission by 12% among patients hospitalized with heart failure in the US.

Finerenone Reduces CV Risk in T2D and CKD, Regardless of ASCVD History

April 07, 2022

A prespecified analysis of FIDELITY details the effects of finerenone against placebo therapy for reducing the risk of cardiovascular events based on history of ASCVD among patients with type 2 diabetes and chronic kidney disease.

Comparing Initiation of SGLT2i/GLP-1 RA Combination Therapy to Monotherapy

April 06, 2022

A study from Intermountain Healthcare provides insight into the tolerability and clinical impact and tolerability of initiating combination therapy with both SGLT2 inhibitors and GLP-1 RAs compared against monotherapy with either agent.